Evidence map›Paper›PMID 35595873›Full record

ArticleNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2022

Segmental spinal neurofibromatosis 1: a novel phenotype.

Nida Fatima, Anna La Dine, Zachary R Barnard, Gregory P Lekovic

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 92% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Nida FatimaDepartment of Neurosurgery, House Clinic, The House Institute Foundation, Los Angeles, CA, USA. nfatima@hifla.org.ORCID http://orcid.org/0000-0002-0976-888X
Anna La DineDepartment of Neurosurgery, House Clinic, The House Institute Foundation, Los Angeles, CA, USA.
Zachary R BarnardDepartment of Neurosurgery, House Clinic, The House Institute Foundation, Los Angeles, CA, USA.
Gregory P LekovicDepartment of Neurosurgery, House Clinic, The House Institute Foundation, Los Angeles, CA, USA.
House Clinic · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionSegmental neurofibromatosis (SNF) is a rare subtype of neurofibromatosis (NF). The disease is characterized by features circumscribed to one or more body cutaneous and/or subcutaneous segments. This is a classic example of somatic mosaicism which occurs by postzygotic mut ation of the NF1 gene late in the course of embryonic development affecting localized neural crest lines in the fetus. Spinal neurofibromatosis, on the other hand, is characterized by histologically proven bilateral neurofibromas of the spinal roots.

methodsHereby we describe a novel manifestation of spinal SNF.

resultsOur case report demonstrated one patient who had segmental spinal expression of the disease classified as true mosaic/segmental NF1 along with its management plan treated at one of the largest NF1 centers to exist.

conclusionThis will aid in understanding the rare clinical presentation and treatment options for this novel phenotype.

Indexed as

NeurofibromatosesNeurofibromatosis 1Genes, Neurofibromatosis 1HumansMosaicismPhenotypeMosaicismNeurofibromatosisSegmental neurofibromatosis

Identifiers

PMID35595873
OpenAlexW4281254677

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.